cadralazine has been researched along with Left Ventricular Hypertrophy in 2 studies
cadralazine: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"This study compared the effects of 1 year of monotherapy with a calcium-channel antagonist (nilvadipine; NIL), an angiotensin-converting enzyme (ACE) inhibitor (temocapril; TEM), or a new vasodilator (cadralazine; CAD) on left ventricular (LV) hypertrophy in essential hypertension." | 5.08 | The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors. ( Inoue, H; Oh-hashi, S; Takata, M; Tomita, S; Ueno, H; Yasumoto, K, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ueno, H | 2 |
Takata, M | 2 |
Tomita, S | 2 |
Oh-hashi, S | 1 |
Yasumoto, K | 2 |
Inoue, H | 2 |
Tomoda, F | 1 |
2 trials available for cadralazine and Left Ventricular Hypertrophy
Article | Year |
---|---|
The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial | 1997 |
Different effects of temocapril and cadralazine on electrocardiographic voltages and left ventricular mass in patients with essential hypertension.
Topics: Aged; Antihypertensive Agents; Echocardiography; Electrocardiography; Female; Humans; Hypertension; | 1999 |